CONTROLLED SUBSTANCES-OPIOIDS Senate SponsorsSen. Mattie Hunter-Jacqueline Y. Collins 1/10/2023SenateSession Sine Die 720 ILCS 570/316Amends the Illinois Controlled Substances Act. Provides that specified requirements also apply to opioid treatment programs that are licensed or certified by the Department of Human Services' Division of Substance Use Prevention and Recovery and are authorized by the federal Drug Enforcement Administration to prescribe Schedule II, III, IV, or V controlled substances for the treatment of opioid use disorders. Requires opioid treatment programs to attempt to obtain written patient consent, document attempts to obtain the written consent, and not transmit information without patient consent. Provides that the documentation obtained shall not be utilized for law enforcement purposes. Provides that treatment of a patient shall not be conditioned upon his or her written consent. Makes other changes. 2/26/2021SenateFiled with Secretary by Sen. Mattie Hunter 2/26/2021SenateFirst Reading 2/26/2021SenateReferred to Assignments 3/12/2021SenateAdded as Chief Co-Sponsor Sen. Jacqueline Y. Collins 1/10/2023SenateSession Sine Die